Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
UF-KURE19 / Case Comprehensive Cancer Center, Kure.ai
CASE2422, NCT05400109: Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas	Active, not recruiting	1	10	US	UF-KURE19 CAR-T cells, Fludarabine, Fludara®, Fludarabine Phosphate, Cyclophosphamide, Cytoxan ®, Endoxan®, Neosar®, Procytox®, Revimmune®, Cycloblastin®	Changchun Deng, MD	Non Hodgkin Lymphoma	10/24	04/25